Literature DB >> 29461915

A novel method for automated assessment of megakaryocyte differentiation and proplatelet formation.

M Salzmann1, B Hoesel1, M Haase1, M Mussbacher1, W C Schrottmaier1, J B Kral-Pointner1, M Finsterbusch1, A Mazharian2, A Assinger1, J A Schmid1.   

Abstract

Transfusion of platelet concentrates represents an important treatment for various bleeding complications. However, the short half-life and frequent contaminations with bacteria restrict the availability of platelet concentrates and raise a clear demand for platelets generated ex vivo. Therefore, in vitro platelet generation from megakaryocytes represents an important research topic. A vital step for this process represents accurate analysis of thrombopoiesis and proplatelet formation, which is usually conducted manually. We aimed to develop a novel method for automated classification and analysis of proplatelet-forming megakaryocytes in vitro. After fluorescent labelling of surface and nucleus, MKs were automatically categorized and analysed with a novel pipeline of the open source software CellProfiler. Our new workflow is able to detect and quantify four subtypes of megakaryocytes undergoing thrombopoiesis: proplatelet-forming, spreading, pseudopodia-forming and terminally differentiated, anucleated megakaryocytes. Furthermore, we were able to characterize the inhibitory effect of dasatinib on thrombopoiesis in more detail. Our new workflow enabled rapid, unbiased, quantitative and qualitative in-depth analysis of proplatelet formation based on morphological characteristics. Clinicians and basic researchers alike will benefit from this novel technique that allows reliable and unbiased quantification of proplatelet formation. It thereby provides a valuable tool for the development of methods to generate platelets ex vivo and to detect effects of drugs on megakaryocyte differentiation.

Entities:  

Keywords:  CellProfiler; computer-assisted image analysis; megakaryocytes; megakaryopoiesis; proplatelets; thrombopoiesis

Mesh:

Year:  2018        PMID: 29461915     DOI: 10.1080/09537104.2018.1430359

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  5 in total

1.  Mitochondrial dynamics and reactive oxygen species initiate thrombopoiesis from mature megakaryocytes.

Authors:  Sonia Poirault-Chassac; Valérie Nivet-Antoine; Amandine Houvert; Alexandre Kauskot; Evelyne Lauret; René Lai-Kuen; Isabelle Dusanter-Fourt; Dominique Baruch
Journal:  Blood Adv       Date:  2021-03-23

2.  Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis.

Authors:  Jiansong Huang; Xin Huang; Yang Li; Xia Li; Jinghan Wang; Fenglin Li; Xiao Yan; Huanping Wang; Yungui Wang; Xiangjie Lin; Jifang Tu; Daqiang He; Wenle Ye; Min Yang; Jie Jin
Journal:  Front Med       Date:  2021-11-18       Impact factor: 9.927

3.  High-content, label-free analysis of proplatelet production from megakaryocytes.

Authors:  Shauna L French; Prakrith Vijey; Kyle W Karhohs; Adrian R Wilkie; Lillian J Horin; Anjana Ray; Benjamin Posorske; Anne E Carpenter; Kellie R Machlus; Joseph E Italiano
Journal:  J Thromb Haemost       Date:  2020-08-23       Impact factor: 16.036

4.  Automated image analysis of stained cytospins to quantify Schwann cell purity and proliferation.

Authors:  Tamara Weiss; Lorenz Semmler; Flavia Millesi; Anda Mann; Maximilian Haertinger; Manuel Salzmann; Christine Radtke
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

5.  Adipose Triglyceride Lipase Deficiency Attenuates In Vitro Thrombus Formation without Affecting Platelet Activation and Bleeding In Vivo.

Authors:  Madeleine Goeritzer; Stefanie Schlager; Katharina B Kuentzel; Nemanja Vujić; Melanie Korbelius; Silvia Rainer; Dagmar Kolb; Marion Mussbacher; Manuel Salzmann; Waltraud C Schrottmaier; Alice Assinger; Axel Schlagenhauf; Corina T Madreiter-Sokolowski; Sandra Blass; Thomas O Eichmann; Wolfgang F Graier; Dagmar Kratky
Journal:  Cells       Date:  2022-03-01       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.